Clinical Trial Update: A Study Comparing Blood Flow and Clinical and Safety Effects of the Addition of Natrecor (Nesiritide), Placebo or Intravenous Nitroglycerin to Standard Care for the Treatment of Worsening Congestive Heart Failure. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether adding nesiritide to standard care improves blood flow, clinical outcomes, and safety in worsening congestive heart failure, co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure
• Heart Failure in Acute Coronary Syndrome

Drugs mentioned

• NITROGLYCERIN (Nitroglycerin)
• Natrecor (nesiritide)

Snippet

Sponsor: Scios, Inc. | Conditions: Symptomatic Decompensated Congestive Heart Failure, Congestive Heart Failure in Acute Coronary Syndrome | Phase 3 | Status: COMPLETED